Avior Wealth Management LLC Buys 2,108 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Avior Wealth Management LLC raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 13.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,814 shares of the company’s stock after buying an additional 2,108 shares during the quarter. Avior Wealth Management LLC’s holdings in Option Care Health were worth $600,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Financial Management Professionals Inc. bought a new position in shares of Option Care Health during the third quarter valued at approximately $29,000. First Horizon Advisors Inc. purchased a new position in Option Care Health in the 3rd quarter worth about $37,000. Advisors Asset Management Inc. lifted its holdings in Option Care Health by 121.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,337 shares of the company’s stock valued at $42,000 after buying an additional 733 shares in the last quarter. NewEdge Advisors LLC boosted its position in Option Care Health by 1,031.9% in the 1st quarter. NewEdge Advisors LLC now owns 1,562 shares of the company’s stock valued at $50,000 after buying an additional 1,424 shares during the period. Finally, Headlands Technologies LLC grew its stake in Option Care Health by 5,796.7% in the 3rd quarter. Headlands Technologies LLC now owns 1,769 shares of the company’s stock worth $57,000 after acquiring an additional 1,739 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Trading Up 2.1 %

NASDAQ OPCH opened at $30.90 on Friday. The company’s 50-day simple moving average is $32.31 and its two-hundred day simple moving average is $31.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The company has a market capitalization of $5.37 billion, a price-to-earnings ratio of 21.02, a price-to-earnings-growth ratio of 1.72 and a beta of 1.22. Option Care Health, Inc. has a one year low of $24.23 and a one year high of $35.74.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, February 22nd. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The firm had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period in the previous year, the company posted $0.26 EPS. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. Equities analysts forecast that Option Care Health, Inc. will post 1.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the stock in a transaction dated Monday, February 26th. The shares were acquired at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on OPCH shares. Jefferies Financial Group lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research raised their price objective on Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.